All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene

Leukemia. 2013 Jul;27(7):1606-10. doi: 10.1038/leu.2012.371. Epub 2012 Dec 28.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Arsenic Trioxide
  • Arsenicals / therapeutic use*
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / genetics*
  • Male
  • Middle Aged
  • Oncogene Proteins, Fusion / genetics
  • Oxides / therapeutic use*
  • Receptors, Retinoic Acid / genetics*
  • Retinoic Acid Receptor alpha
  • STAT5 Transcription Factor / genetics*
  • Tretinoin / therapeutic use*

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oncogene Proteins, Fusion
  • Oxides
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • STAT5 Transcription Factor
  • STAT5B protein, human
  • Tretinoin
  • Arsenic Trioxide